KALA BIO, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $78.9M | $16.8M | $92.1M |
| FY2022 | $37.9M | $19.0M | $70.5M |
| FY2023 | $34.2M | $7.5M | $50.9M |
| FY2024 | $20.1M | $12.3M | $51.2M |
| FY2025 | — | $7.0M | $7.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $78.9M | $16.8M | $92.1M |
| FY2022 | $37.9M | $19.0M | $70.5M |
| FY2023 | $34.2M | $7.5M | $50.9M |
| FY2024 | $20.1M | $12.3M | $51.2M |
| FY2025 | — | $7.0M | $7.6M |